Artiva Biotherapeutics, Inc.
ARTV
8 insider filings · Latest: May 19, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 28 4:34 PM | GC Corp.10% Owner | Purchase | 1,432,291 | $11.52 | $16.5M | 1,607,734(I) | View → |
| May 19, 2026 | May 19 9:52 PM | Heather RaymonSVP, Research and Development | Sale | 3,095 | $9.01 | $27.9K | 148,228(D) | View → |
| May 19, 2026 | May 19 9:52 PM | Christopher HoranChief Tech Operations Officer | Sale | 7,002 | $9.01 | $63.1K | 293,450(D) | View → |
| May 19, 2026 | May 19 9:51 PM | Jennifer BushCOO, CLO, Compliance Officer | Sale | 8,790 | $9.01 | $79.2K | 337,920(D) | View → |
| May 19, 2026 | May 19 9:50 PM | Subhashis BanerjeeChief Medical Officer | Sale | 7,037 | $9.01 | $63.4K | 144,963(D) | View → |
| May 19, 2026 | May 19 9:50 PM | Fred AslanDirector, Chief Executive Officer | Sale | 27,116 | $9.01 | $244.3K | 1,535,082(D) | View → |
| May 11, 2026 | May 13 5:45 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 6,510,416 | $11.52 | $75.0M | 15,203,995(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 19 8:11 AM | Gines Diego MirallesPresident & Head of R&D | Grant/Award | 232,500 | $9.22 | 232,500(D) | View → |
| May 11, 2026 | May 13 5:45 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,170,138 | $0.0001 | 2,170,138(I) | View → |